Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 10, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 13, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0002104848-26-000006
Filed / recorded
Feb 13, 2026, 1:28 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Sabra Health Care REIT, Inc.
Issuer CIK
1492298
Ticker
SBRA
Reporting person
Darrin Smith
Relationship
Officer
Officer title
Executive VP, CIO & Secretary
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 10, 2026
Transaction code
A
Shares / units
5,483
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
110,674
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 1,152 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested and were settled immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025.